BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//About - ECPv6.16.2//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:About
X-ORIGINAL-URL:https://www.winona.edu/about
X-WR-CALDESC:Events for About
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Chicago
BEGIN:DAYLIGHT
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
TZNAME:CDT
DTSTART:20240310T080000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
TZNAME:CST
DTSTART:20241103T070000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
TZNAME:CDT
DTSTART:20250309T080000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
TZNAME:CST
DTSTART:20251102T070000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
TZNAME:CDT
DTSTART:20260308T080000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
TZNAME:CST
DTSTART:20261101T070000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/Chicago:20250227T080000
DTEND;TZID=America/Chicago:20250227T163000
DTSTAMP:20260530T223454
CREATED:20250122T213827Z
LAST-MODIFIED:20250122T213914Z
UID:10000503-1740643200-1740673800@www.winona.edu
SUMMARY:Cytotheryx Company Takeover
DESCRIPTION:On Feb. 27\, Cytotheryx is partnering with WSU’s College of Business and College of Science & Engineering to bring industry expertise directly to the classroom for a company takeover event. \n\n\n\nThis initiative aims to connect students with real-world applications of their studies in marketing\, accounting\, medical sciences\, and more to offer a unique opportunity to learn from professionals at the forefront of innovation. \n\n\n\nEvent Agenda\n\n\n\n\nGuest Lectures\n\n\n\nInteractive Case Study or Q&A Sessions\n\n\n\nNetworking and Career Insights\n\n\n\nLunch & Learn\n\n\n\n\n \n\n\n\nAbout Cytotheryx\n\n\n\nCytotheryx\, Inc.\, is an emerging biotechnology company specializing in developing a consistent and high-quality source of primary human hepatocytes (liver cells) to advance research and therapeutic applications. Their work addresses a critical need in medicine because current supplies of human hepatocytes are limited\, inconsistent\, and dependent on organ donations. \n\n\n\nCytotheryx’ proprietary platform enables scalable production of these cells for various uses\, including drug metabolism studies\, disease modeling\, and regenerative medicine. On the clinical side\, their innovations support treatments like cell therapy\, bioartificial liver devices\, and hepatocyte transplantation\, harnessing the scalable supply of hepatocytes to transform care for acute\, chronic\, and rare forms of liver disease. \n\n\n\nTheir mission is grounded in values like innovation\, responsibility\, and ethical research\, aiming to create life-changing solutions for millions affected by liver diseases. Cytotheryx collaborates with key partners\, including Mayo Clinic\, to expand the applications of their technology. \n\n\n\n\n\nVenues\n\n\n\n\n\n\n\nContact
URL:https://www.winona.edu/about/event/cytotheryx-company-takeover/
LOCATION:Somsen Hall\, 175 West Mark Street\, Winona\, MN\, 55987\, United States
CATEGORIES:Academics,College of Business,College of Science & Engineering,Colleges
ATTACH;FMTTYPE=image/jpeg:https://www.winona.edu/about/wp-content/uploads/sites/3/2024/11/WSU-students-presentation-audience-feature-2019-02-18.jpg
ORGANIZER;CN="Liz Schwanke":MAILTO:collegeofbusiness@winona.edu
END:VEVENT
END:VCALENDAR